A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Lactiplantibacillus plantarum Lp05 as an Adjunct to Helicobacter pylori Eradication Therapy
To investigate the clinical efficacy of Lactiplantibacillus plantarum Lp05 as an adjunct to conventional quadruple therapy for H. pylori eradication, assessing its potential to improve the eradication rate, alleviate gastrointestinal symptoms, reduce adverse events, and modulate the gut microbiota.